Professional Documents
Culture Documents
SIMPOSIO
REFERENCIAS BIBLIOGRFICAS
1. Department of Health. The path of least resistance. Main report. Standing Med
ical Advisory Committee. Sub-group on antimicrobial resistance. Londres: Departm
ent of Health. Publication Unit PHLS. Headquarters Office; 1998.
2. Mendoza C, Velsquez R, Mercado L, y col. Susceptibilidad antimicrobiana de Sta
phylococcus aureus sensible, con sensibilidad borderline y resistentes a la metici
lina. Rev Med Hered. 2003;14(4):181-185.
3. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physicia
n in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:4
71-485.
4. http://www.odci.gov/cia/reports/nie/report/nie99-17d.html (Visitado el 10 de
mayo del 2006).
5. Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA. Changes in antib
iotic use, cost and consumption after an antibiotic restriction policy applied b
y infectious disease specialists. Jpn J Infect Dis. 2005; 58(6):338-343.
6. Smith R, Coast J. Antimicrobial Resistance: A global response. Bull WHO. 2002
; 80;126-133.
7. Ochoa T. Resistencia de Streptococcus pneumoniae a penicilina en portadores n
asofarngeos menores de 2 aos. Rev Med Hered. 1998; 9(2): 56-62.
8. Bamberger DM, Boyd SE. Management of Staphylococcus aureus infections. Am Fam
Physician. 2005;72(12):2474-2481.
9. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Infecti
ous Diseases Society of America. Update of practice guidelines for the managemen
t of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 20
03;37:1405-1433.
10. Turner, et al. Telithromycin. Ann Intern Med 2006;144: 447-448.
11. Maguia C, Solari L. Nuevas y viejas quinolonas. Rev Med Hered. 2002;13:153-16
0.
12.Hooper D. Mechanisms of action and resistance of older and newer fluoroquinol
ones. Clin Infecti Dis. 2000;31:S24-S28.
13. Saravolatz LD, Leggett J. Gatifloxacin, gemifloxacin, and moxifloxacin: the
role of 3 newer fluoroquinolones. Clin Infect Dis. 2003;37:210-215
14. Ginsburg AS, Hooper N, Parrish N, et al. Fluoroquinolone resistance in newly
diagnosed tuberculosis. Clin Infect Dis. 2003;37:448-452
15. Drugs 2004. Newer Treatment Options for Skin and Soft Tissue Infections. 200
4, 64(15):1621-1642
16. http://www.remediar.gov.ar/pdf/uso_racional.pdf (Visitado 10 de mayo del 20
06).